Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Southern Acids (M) BhdXKLS:5134 +1.31%70 ROC (Joel Greenblatt) % is 57.69% as of Mar. 2026, which is 161% above its 10-year median of 22.07. GuruFocus rates XKLS:5134 with a GF Score™ of 70/100 and a GF Value™ of RM2.88 (Fairly Valued). The stock has 4 warning signs investors should review. Among 562 Conglomerates companies, Southern Acids (M) Bhd ranks better than 69.4% on this metric.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Southern Acids (M) Bhd's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 57.69%.
The historical rank and industry rank for Southern Acids (M) Bhd's ROC (Joel Greenblatt) % or its related term are showing as below:
XKLS:5134'
s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 14.61 Med: 22.07 Max: 43.12
Current: 29.3
During the past 13 years, Southern Acids (M) Bhd's highest ROC (Joel Greenblatt) % was 43.12%. The lowest was 14.61%. And the median was 22.07%.
XKLS:5134's ROC (Joel Greenblatt) % is ranked better than 69.4% of 562
companies
in the Conglomerates industry
Industry Median: 14.68
vs XKLS:5134: 29.30
Southern Acids (M) Bhd's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was -0.10% per year.
Southern Acids (M) Bhd (XKLS:5134) ROC (Joel Greenblatt) % Explanation
The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.
Southern Acids (M) Bhd ROC (Joel Greenblatt) % Related Terms
Southern Acids (M) Bhd ROC (Joel Greenblatt) % Historical Data
* Premium members only.
The historical data trend for Southern Acids (M) Bhd's ROC (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Southern Acids (M) Bhd ROC (Joel Greenblatt) % Chart
XKLS:5134 vs HON, MMM: ROC (Joel Greenblatt) % Comparison
For the Conglomerates subindustry, Southern Acids (M) Bhd's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Southern Acids (M) Bhd ROC (Joel Greenblatt) % vs Conglomerates Industry
For the Conglomerates industry and Industrials sector, Southern Acids (M) Bhd's ROC (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Southern Acids (M) Bhd's ROC (Joel Greenblatt) % falls into.
Southern Acids (M) Bhd ROC (Joel Greenblatt) % Calculation
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:
EBIT stands for Earnings Before Interest and Taxes.
Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.
GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.
Note:
The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROC (Joel Greenblatt) % of 57.69% mean?
Southern Acids (M) Bhd (XKLS:5134) has a ROC (Joel Greenblatt) % of 57.69% as of Mar. 2026. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Southern Acids (M) Bhd and its competitors. This is 161% above median its historical median of 22.07. Over the past decade, Southern Acids (M) Bhd's ROC (Joel Greenblatt) % has ranged from 14.61 to 43.12. According to the industry distribution chart, Southern Acids (M) Bhd ranks #172 out of 562 companies in the Conglomerates industry, placing it in the top 30.6%.
Is Southern Acids (M) Bhd's ROC (Joel Greenblatt) % too high?
Southern Acids (M) Bhd's current ROC (Joel Greenblatt) % of 57.69% is 161% above median its 10-year median of 22.07. Over the past 10 years, this metric has ranged from a low of 14.61 to a high of 43.12. The Conglomerates industry median ROC (Joel Greenblatt) % is 14.68. Southern Acids (M) Bhd's value of 57.69% is 293% above this industry median. Based on the distribution chart, Southern Acids (M) Bhd ranks #172 out of 562 companies in the Conglomerates industry, which is above the industry midpoint. Overall, Southern Acids (M) Bhd has a GF Score™ of 70/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Southern Acids (M) Bhd's ROC (Joel Greenblatt) % compare to HON and MMM?
According to the Conglomerates industry distribution chart, Southern Acids (M) Bhd ranks #172 out of 562 companies for ROC (Joel Greenblatt) %. This puts Southern Acids (M) Bhd in the upper half of its industry. The industry median ROC (Joel Greenblatt) % is 14.68. Southern Acids (M) Bhd's value of 57.69% is 293% above this benchmark. Historically, Southern Acids (M) Bhd's own ROC (Joel Greenblatt) % has ranged from 14.61 to 43.12 over the past decade. While the company's 10-year median is 22.07 vs. the industry median of 14.68, Southern Acids (M) Bhd has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Conglomerates company?
The median ROC (Joel Greenblatt) % among Conglomerates companies is 14.68, based on 562 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Southern Acids (M) Bhd's current ROC (Joel Greenblatt) % of 57.69% is 293% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Southern Acids (M) Bhd and its competitors. For the Conglomerates industry, the median ROC (Joel Greenblatt) % is 14.68 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Southern Acids (M) Bhd's current ROC (Joel Greenblatt) % is 57.69%, which is 161% above median its own 10-year median of 22.07. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Southern Acids (M) Bhd stock overvalued right now?
Based on GuruFocus' analysis, Southern Acids (M) Bhd (XKLS:5134) is currently considered Fairly Valued. The stock's GF Value™ is RM2.88, compared to a current price of RM3.10 — trading 7.6% above its estimated fair value. The current ROC (Joel Greenblatt) % is 57.69%, which is 161% above median its 10-year median of 22.07 and 293% above the Conglomerates industry median of 14.68. Southern Acids (M) Bhd's overall GF Score™ is 70/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For Southern Acids (M) Bhd (XKLS:5134), the current ROC (Joel Greenblatt) % is 57.69% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Southern Acids (M) Bhd (XKLS:5134) Overvalued in 2026?
Based on GuruFocus' analysis, Southern Acids (M) Bhd stock appears to be overvalued.
The current stock price of RM3.10 is trading 7.6% above its estimated GF Value™ of RM2.88.
GuruFocus considers Southern Acids (M) Bhd to be Fairly Valued.
Key valuation signals for XKLS:5134:
ROC (Joel Greenblatt) %: 57.69% (161% above median its 10-year median of 22.07)
GF Value™: RM2.88 vs. price of RM3.10 (7.6% above fair value)
Industry Position: 293% above the Conglomerates median (#172 of 562)
No single metric tells the full story. See the XKLS:5134 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Southern Acids (M) Bhd is an investment holding and the provision of a management service company. The company's operating segment includes Oleochemical; Healthcare; Milling and Cultivation and Investments and services. It generates maximum revenue from the Milling and Cultivation segment. The Oleochemical Segment is involved in the manufacturing and marketing of fatty acids and glycerine. Its Milling and Cultivation Segment is principally engaged in the processing of Fresh Fruit Bunches. Geographically, it has a presence in Malaysia, Indonesia, Europe, America, and Other Countries.
70GF Score
Get the complete analysis for XKLS:5134
ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:5134 has been successfully added to your 
